Neurological Disease

Blogs

Amylyx’s Dedication to Neurodegenerative Disease Research: Insights Gained and Future Directions
Approvals News

Aqneursa Joins the Ranks with Miplyffa, Expands Niemann-Pick Disease Type C Treatments
Approvals News

Miplyffa Approved as First Treatment for Niemann-Pick Disease Type C (NPC)
Blogs

Patient-Centered Innovation for Rare Seizure Disorders: Insights from Marinus Pharmaceuticals
Blogs

World Alzheimer’s Day 2024: Innovative Therapies and More

Advancing Epilepsy Research: New Strategies for Drug-Resistant Epilepsy and Associated Comorbidities

September 23, 2024
Approvals News

Zunveyl Approved as New Oral Med for Alzheimer’s Disease
Approvals News

Vyvgart Hytrulo: A New Innovation in CIDP Treatment in Decades
Blogs

Pioneering New Frontiers: Ovid Therapeutics’ Journey to Revolutionize Epilepsy and CNS Treatment
Blogs

Brain Awareness Week 2024: A Spotlight on Brain Health and New Treatments for Neurological Diseases
Blogs

Cognitive and Neuropsychiatric Disorders Drug Development, Featuring Dr. Adam Kaplin, Cofounder, President, CSO, MIRA Pharmaceuticals – Xtalks Life Science Podcast Ep. 141
Biotech News

Novartis to Pay Voyager $100 Million Upfront for Gene Therapies
Blogs

Dr. Lahar Mehta Speaks About New Trial to Evaluate ALS Drug for Progressive Supranuclear Palsy – Xtalks Life Science Podcast Ep. 136
Blogs

Building Connections on World MS Day 2023

Branching Out in the Area of Genetic Neurology: Collaborating with Australian Clinical Trial Experts

May 19, 2020
Life Science News

Miniaturized Neural Drug Delivery System Supports Targeted Dosing in the Brain